Seres Therapeutics (MCRB) Return on Sales [ROS] (2016 - 2026)
Seres Therapeutics (MCRB) posted Return on Sales [ROS] of -2890.35% for Q2 2026, up 2949.59 percentage points from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) Return on Sales [ROS] (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Seres Therapeutics was -4462.77%; for FY2025, it was -11910.14%.
- Annual Return on Sales [ROS] shows a five-year change of -11644.81 percentage points (FY2020 to FY2025).
- In prior years, Seres Therapeutics' Return on Sales [ROS] was -2524.05% in FY2022 (-2479.55 pp) and -44.50% in FY2021 (+220.83 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Sales [ROS] since Q2 2023.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2023, with a gain of 5246.81 percentage points; the weakest was Q3 2023, with a drop of 12666.35 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -5839.94% (Q1 2026), -4423.97% (Q4 2025) and -6403.70% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 28.37% |
| 10 | Seres Therapeutics | 20.54 Mn | -118.29 Mn | - | -2,890.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,890.35% |
| Mar 31, 2026 | -5,839.94% |
| Dec 31, 2025 | -4,423.97% |
| Sep 30, 2025 | -6,403.70% |
| Mar 31, 2024 | -12,744.06% |
| Dec 31, 2023 | -9,832.76% |
| Sep 30, 2023 | -14,382.58% |
| Jun 30, 2023 | 39.16% |
| Mar 31, 2023 | -13,518.77% |
| Dec 31, 2022 | -177.54% |
| Sep 30, 2022 | -1,716.23% |
| Jun 30, 2022 | -5,207.65% |
| Mar 31, 2022 | -3,734.16% |
| Dec 31, 2021 | -684.56% |
| Sep 30, 2021 | 53.98% |
| Jun 30, 2021 | -914.73% |
| Mar 31, 2021 | -617.80% |
| Dec 31, 2020 | -101.90% |
| Sep 30, 2020 | -2,116.80% |
| Jun 30, 2020 | -339.87% |
API Access
Seres Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();